Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07300540 · ClinicalTrials.gov registry record · NA

Real-World Study of a Calcium Sodium Phosphosilicate Anti-Sensitivity Toothpaste for Dentin Hypersensitivity Relief

A NA study of Dentin Sensitivity, sponsored by HALEON.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT07300540: Recruiting NA study of Dentin Sensitivity, sponsored by HALEON.

NCT07300540 is a NA study of Dentin Sensitivity that is actively recruiting participants, run by HALEON. The registered enrollment target is 500 participants, above the 110-participant average among 3 other Dentin Sensitivity trials with a reported enrollment target (355% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07300540, a NA study of Dentin Sensitivity, is actively recruiting participants, sponsored by HALEON.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to evaluate the impact of a commercially available desensitizing dentifrice containing 5 percent (%) Calcium sodium phosphosilicate (CSPS) on oral health related quality of life (OHrQoL) in a DH (Dentin Hypersensitivity) population in a real-world setting.

Primary Outcome

The DHEQ is used to measure how DH affects participants quality of life. Section 2 has 34 questions in grouped into 5 domains (Restrictions, Adaptation, Social Impact, Emotional Impact, and Identity). Participants scored each question using a 7-point scale ranging from 1 to 7, where 1= strongly disagree, 2=disagree, 3=disagree a little, 4=neither agree nor disagree, 5=agree a little, 6=agree, and 7=strongly agree. The total score will be derived from the sum of scores across all domains and it r

Conditions Studied

Interventions

  • OTHER Calcium sodium phosphosilicate (CSPS) Toothpaste

Study Locations (1)

Nevada

  • Citruslabs (Virtual Site) - Las Vegas

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2026-03-04
Est. Completion 2026-11
Phase NA
HALEON

34 total trials

What NCT07300540 shows while recruiting

NCT07300540 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 110-participant average among 3 other Dentin Sensitivity trials with a reported enrollment target (355% higher).

The record links to 1 condition, with Dentin Sensitivity appearing as the primary indexed condition, and to 1 intervention - of which Calcium sodium phosphosilicate (CSPS) Toothpaste is the first listed.

NCT07300540 reports a single indexed study location in Nevada.

Frequently Asked Questions

What is clinical trial NCT07300540 about?

NCT07300540 is a clinical study titled "Real-World Study of a Calcium Sodium Phosphosilicate Anti-Sensitivity Toothpaste for Dentin Hypersensitivity Relief". The aim of this study is to evaluate the impact of a commercially available desensitizing dentifrice containing 5 percent (%) Calcium sodium phosphosilicate (CSPS) on oral health related quality of life (OHrQoL) in a DH (Dentin Hypersensitivity) population in a real-world setting.

What is the current status of trial NCT07300540?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2026-03-04. Estimated completion is 2026-11.

What conditions does trial NCT07300540 study?

This clinical trial studies the following conditions: Dentin Sensitivity.

What interventions are being tested in trial NCT07300540?

The interventions under investigation include: Calcium sodium phosphosilicate (CSPS) Toothpaste (OTHER).

Who is sponsoring clinical trial NCT07300540?

This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07300540 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dentin Sensitivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07300540, the US trial registry maintained by the National Library of Medicine. NCT07300540 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.